The Journal of Critical Care Medicine (Oct 2015)

Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) – Early Biomarker for Acute Kidney Injury in Critically Ill Patients

  • Bianca Grigorescu,
  • Raluca Fodor,
  • Veres Mihaly,
  • Orlandea Monica,
  • Badea Judita,
  • Hlavathy Katalin,
  • Cioc Adrian

DOI
https://doi.org/10.1515/jccm-2015-0023
Journal volume & issue
Vol. 1, no. 4
pp. 154 – 161

Abstract

Read online

Introduction: NGAL (Neutrophil Gelatinase Associated Lipocalin) is a biomarker recently introduced into clinical practice for the early diagnosis of acute kidney injury (AKI). The aim of this study was to correlate the plasmatic NGAL value determined at admission with clinical progression and severity of AKI in critically ill patients.

Keywords